Rhythm Pharmaceuticals, Inc. RYTM Non-cash rent expense
Non-cash rent expense at other companies
Other financials
Where this comes from
Reported directly by Rhythm Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept rytm:DeferredRentExpense.
The official record: Rhythm Pharmaceuticals, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rhythm Pharmaceuticals, Inc.'s non-cash rent expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Rhythm Pharmaceuticals, Inc.'s non-cash rent expense?
- Rhythm Pharmaceuticals, Inc. (RYTM) reported non-cash rent expense of $113K in Q1 2026.
- How has Rhythm Pharmaceuticals, Inc.'s non-cash rent expense changed year-over-year?
- Rhythm Pharmaceuticals, Inc.'s non-cash rent expense increased by 2.7% year-over-year, from $110K to $113K.
- What is the long-term trend for Rhythm Pharmaceuticals, Inc.'s non-cash rent expense?
- Over 4 years (2021 to 2025), Rhythm Pharmaceuticals, Inc.'s non-cash rent expense has grown at a 14.4% compound annual growth rate (CAGR), from -$250K to $428K.
- What does non-cash rent expense mean?
- This represents the difference between rent expense recognized on a straight-line basis and the actual cash payments made under lease agreements. It highlights the timing mismatch between accounting recognition and cash outflows for facility leases.